Cognito Therapeutics News

Cognito Raises $105M for Alzheimer’s Device

March 9, 2026

Cognito Therapeutics closes oversubscribed $105M Series C to fund pivotal Alzheimer's trial readout and 2027 launch of Spectris neuromodulation device using light/sound.